Ranitidine
Product Images NDC 55648-907

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 55648-907). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Ranitidine Tablets Structure)

Chemical structure of the active ingredient Ranitidine shown as a 2D molecular diagram, including atoms and bond connections, and a hydrochloride (HCl) component.*

FDA Label Image

Bulk Label (Ranitidine Tablets 150 mg Bulk Label)

Label for Ranitidine Tablets USP 150 mg by Wockhardt Limited, Mumbai, India. The bulk pack contains 5,000 tablets for repackaging only. It includes storage instructions, mentions that each tablet contains Ranitidine Hydrochloride equivalent to 150 mg of Ranitidine, and shows distribution details by Wockhardt USA LLC, Parsippany, NJ. The label states it is Rx only and features a barcode and the Wockhardt logo.*

FDA Label Image

Bulk Label (Ranitidine Tablets 300 mg Bulk Label)

Label for Ranitidine Tablets, USP 300 mg by Wockhardt Limited. The bulk pack contains 3,750 tablets and is marked for repackaging only. It includes storage instructions, active ingredient information, manufacturing and distributing details, as well as a barcode and NDC 64679-907-09.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.